#CancerScience
Researchers at UT Austin have identified how dormant cancer cells can block immune attacks, a discovery that could help improve future immunotherapies for hard-to-treat cancers.

news.utexas.edu/2023/10/09/c...

#CancerResearch #Immunotherapy #CancerScience #TCSC
Cancer Drug Restores Immune System’s Ability to Fight Tumors
AUSTIN, Texas — A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The University of
news.utexas.edu
August 6, 2026 at 8:59 AM
Scientists at the Josep Carreras Leukaemia Research Institute found that restoring a missing protein called HDAC7 in diffuse large B cell lymphoma cells can actually slow or stop tumor growth. medicalxpress.com/news/2026-04... #DLBCL #BloodCancer #LymphomaResearch #CancerScience #TCSC
Protective 'switch' in most common blood cancer opens new doors for diagnosis and treatment
A new study published in The Journal of Immunology by researchers at the Josep Carreras Leukaemia Research Institute (IJC) has uncovered a crucial biological "off switch" in diffuse large B cell lymph...
medicalxpress.com
April 22, 2026 at 7:46 PM
Smarter cancer treatment means understanding the mutation, not just the diagnosis. That is where real progress starts. #CancerScience #Oncology #TCSC
April 14, 2026 at 7:39 AM
uPAR shows up on the most dangerous cancer cells AND the support cells that protect tumors. Targeting both at once could be the breakthrough solid tumor patients have been waiting for. #TCSC #CancerScience #Immunotherapy #CancerBreakthrough
March 31, 2026 at 8:45 AM
A new study helps explain why powerful cancer treatments can work brilliantly for some patients and barely at all for others, with tumours switching on complex programs to block the immune system. #CancerScience #Immunotherapy #TCSC
scitechdaily.com/the-surprisi...
The Surprising Reason Cancer Treatments Don’t Work for Everyone
A new study sheds light on why promising cancer treatments can produce dramatically different results across patients.
scitechdaily.com
March 22, 2026 at 7:15 AM
Researchers are improving how a major #chemotherapy drug reaches tumours. A new delivery system could help paclitaxel travel more efficiently to cancer cells while reducing side effects. #CancerScience #DrugDelivery #TCSC
www.drugtargetreview.com/news/194147/...
New drug delivery system boosts paclitaxel cancer treatment
Explore how paclitaxel and innovative drug delivery systems are changing cancer treatment and improving therapeutic outcomes.
www.drugtargetreview.com
March 17, 2026 at 7:16 AM
Over 400 clinical trials are already exploring cancer vaccines as potential treatments. If successful, they could transform how we prevent recurrence and treat tumors in the future.

#CancerScience #ClinicalTrials #FutureOfMedicine #TCSC
March 15, 2026 at 7:18 AM
From CAR-T approaches to bispecific antibodies, scientists are learning how to guide immune cells directly to cancer. Each clinical trial moves the field a little closer to better, more precise treatments.

#CancerTrials #PrecisionMedicine #CancerScience #TCSC
March 14, 2026 at 8:16 AM
Combining therapies is becoming one of the most powerful strategies in oncology. By activating the immune system while targeting the tumour directly, researchers hope to improve outcomes in early-stage prostate cancer.

#CancerInnovation #Immunotherapy #CancerScience #TCSC
March 14, 2026 at 8:13 AM
Pancreatic cancer remains one of the most challenging diseases in oncology. Discoveries like this gene switch could help turn resistant tumors into ones doctors can actually treat.

#PancreaticCancer #CancerScience #TCSC
March 9, 2026 at 7:51 AM
A popular anti-aging supplement is now raising questions in #cancerresearch. Scientists found molecules linked to longevity may also help cancer cells grow, revealing a complex biological balance researchers must understand.

#Longevity #CancerScience #TCSC

www.sciencealert.com/popular-anti...
Popular Anti-Aging Supplement May Fuel Cancer Growth – Here's Why
A group of natural compounds attracting attention for their anti-aging potential has a dark side.
www.sciencealert.com
March 9, 2026 at 7:47 AM
Scientists at UC San Diego have discovered a way to “rewire” the immune system to fight ovarian cancer. By blocking a key protein, immune cells can be reprogrammed to attack tumors more effectively.

#OvarianCancer #Immunotherapy #CancerScience #MedicalResearch #TCSC

today.ucsd.edu/story/rewiri...
Rewiring Immune System Offers New Path to Better Ovarian Cancer Treatment
A new discovery from UC San Diego researchers could enable easier treatment of high-grade serous ovarian cancer, the most common and aggressive form of ovarian cancer.
today.ucsd.edu
March 6, 2026 at 10:36 AM
New study targets better treatments for pediatric brain cancer. Scientists at Fralin Biomedical Research Institute are working on precision drug delivery to boost effectiveness! #TCSC #PediatricCancer #ChildhoodCancer #TargetedTherapy #CancerBreakthroughs #CancerScience

news.vt.edu/articles/202...
New study aims to improve treatment for pediatric brain cancer
With grant support from The Children’s Cancer Foundation Inc., a nonprofit that serves the Baltimore-Washington region, Fralin Biomedical Research Institute scientists are focused on ending an gliobla...
news.vt.edu
June 11, 2025 at 11:44 AM
Cancer cells fix themselves to survive. But what if we could stop them? New research maps the tangled web of DNA repair genes—and finds where cancer is most vulnerable.
Read @neilosterweil.bsky.social's story here: medicalnewsinsider.substack.com/p/the-fix-is...
#CancerScience #Genetics #DNARepair
The fix is in: stopping cancer cells from repairing themselves
Blocking the interactions that allow DNA repair genes to do their job could be a novel strategy for treating cancers, say researchers in Switzerland.
medicalnewsinsider.substack.com
April 14, 2025 at 4:23 PM
Dr. Umberto Malapelle is shaping the future of precision oncology through biomarker discovery and NGS innovation. He’s President-Elect of ISLB and a featured speaker at #ISLB25.

Learn more: 2025.islb.info

#MeetTheSpeakers #LiquidBiopsy #CancerScience
October 21, 2025 at 6:58 PM
We cover 3-5 cancer research conferences a year distilling standout talks and fresh insights.
Thanks to our readers for caring. And to the speakers: your work shines even brighter in our newsletter 💙
#CancerScience #ConferenceCoverage #CancerResearch #ScienceCommunication bit.ly/3SY9M6V
August 4, 2025 at 12:16 PM
Starving tumors of oxygen can backfire. New study shows hypoxia helps colon cancer grow—by recruiting fibroblasts to the dark side. #CancerScience #ColonCancer #Wnt5a
How Oxygen-Starved Zones Help Colon Cancer Thrive
A new study reveals that low-oxygen zones inside colon tumors reprogram fibroblasts into cancer allies—offering a fresh target for therapy in both cancer and inflammatory diseases.
geekoo.news
May 27, 2025 at 7:00 AM
A #smallclinical by @danafarber.bsky.social builds on @salkinstitute.bsky.social discoveries about the #vitaminD receptor and #tumor microenvironment. Early, not definitive but really encouraging #cancerscience development www.linkedin.com/posts/drmelv...
May 30, 2026 at 7:21 PM
The American Association for Cancer Research (AACR) Annual Meeting is underway in Chicago!

If you're attending the meeting, be sure to connect with our on-site experts!

#AACR2025 #Oncology #CancerResearch #CancerScience #OncologyResearch
April 25, 2025 at 2:52 PM
Attending next week's American Association for Cancer Research (AACR) Annual Meeting?

If so, be sure to connect with our on-site experts! E-mail contact@lumanity.com to schedule time to meet while at the meeting,

#AACR2025 #Oncology #CancerResearch #CancerScience #OncologyResearch
April 17, 2025 at 1:52 PM
🎗️ Observing #SarcomaAwarenessMonth
Sarcoma may be rare, but its complexity demands focused research.
Advances in diagnosis and targeted therapies are improving patient outcomes.
Stay connected to life saving research.
Follow @academaxjournals.bsky.social

#AcademicSky #CancerScience
July 16, 2026 at 6:21 AM